BioCentury
ARTICLE | Top Story

CAT and Genzyme in TGF-beta deal

September 28, 2000 7:00 AM UTC

Cambridge Antibody Technology (LSE:CAT) and GENZ will collaborate on the development and commercialization of human monoclonal antibodies against TGF-beta. Initially the companies will focus on sclero...